Abstract
In response to a tripling in the number of national drug shortages over the prior 10 years, the Food and Drug Administration Safety and Innovation Act was passed in 2012 to give the FDA expanded authority to track and moderate the impact of shortages. These authors analyzed data from the University of Utah's Drug Information Service to …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
